Beryl Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,935,009
Closed -$18M 34
2024
Q4
$18M Buy
+5,935,009
New +$25.9M 4.08% 3

Other funds holding RVNC